Oxford Biomedica completes acquisition of ABL Europe
Oxford BioMedica plc Oxford Biomedica completes acquisition of ABL Europe Strengthens Oxford Biomedica’s position as a global pure-play cell and gene therapy CDMO with multi viral vector capabilit...